Orforglipron CAS 2212021-83-3
CAS: 2212020-52-3
Purity:>99.0%
Molekilè Fòmil: C48H48F2N10O5
Dekri teren
Orforglipron CAS 2212021-83-3 se yon ti molekil GLP-1 agonist reseptè. Nan esè klinik yo, Orforglipron te demontre siyifikatif efikasite nan jesyon pwa pou pasyan obèz oswa ki twò gwo.
| Non pwodwi: | 5 - [(s) - 2,2-dimethyltetrahydro-2h-piran-4-il] -1-[(1s, 2s) -2-methyl-1- (5-oxo-4,5-dihydro-1,2,4-oxozi-oxo-oxo-oxo-oxo-ox- Asid |
| Sinonim: | 1H - indole - 2 - asid karboksilik, 1 - [(1s, 2s) - 1 - (2,5 - Dihydro - 5 {57} diazol - 3 - yl) - 2 - methylcyclopropyl] -5-[(4s) -tetrahydro-2,2-dime thyl-2H-pyran-4-yl]-;5-[(S)-2,2-Dimethyltetrahydro-2H-pyran-4-yl]-1-[(1S,2S)-2-methyl-1-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)cyclopropyl]-1H-indole-2-carboxylic Asid; 1-((1s, 2s) -1-cyano-2-methylcyclopropyl) -5-((s) -2,2-dimethyltetrahydro-2h-piran-4-il) -n-methyl-n-phenyl-1h-indole-2-carboxamide; ) -1- (2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-il) -2-methylcyclopropyl] -5-[(4s) -tetrahydro-2,2-dimethyl-2h-pyran-4-il] -1h-endol {{{{{{{{{{{{-%- |
| CAS: | 2212021-83-3 |
| MF: | C22H25N3O5 |
| MW: | 411.46 |
| Dosye mol: | 2212021-83-3.mol |
|
|
|
| dansite | 1.48 ± 0.1 g/cm3 (prevwa) |
| fòm | Solid |
| pka | 4.55 ± 0.30 (prevwa) |
| koulè | Blan nan Off - Blan |
Nimewo CAS: 2212021-83-3
5-[(S)-2,2-Dimethyl-2H-pyran-4-yl]-1-[(1S,2S)-2-methyl-1-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)cyclopropyl]-1H-indole-2-carboxylic acid
Nimewo CAS: 2212021-61-7
(S) - 2 - (4 - fluoro-3,5-dimethylphenyl) -4-methyl-3- (2-oxo-2,3-dihyd Ro-1H-Imidazol-1-il) -2,4,6,7-Tetrahydro-5h-pirazolo [4,3-C] piridin-5-karboksilik asid tert-butil èste estè

Limit responsabilite nou:
Tout enfòmasyon yo bay sou sit entènèt sa a se pou referans ak etid sèlman, pa gen okenn konsèy medikal, pa pou dyagnostik, tretman pou maladi, konpayi nou an sèlman bay orforglipron poud entèmedyè pou rechèch itilize sèlman.
Baj popilè: Orforglipron CAS 2212021-83-3, Lachin, Swèd, manifaktirè, faktori, en, achte, esansyèl, pri, pou vann, nan stock
Voye rechèch
Ou ka renmen tou




![product-1-1 5-[(S)-2,2-Dimethyltetrahydro-2H-pyran-4-yl]-1-[(1S,2S)-2-methyl-1-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)cyclopropyl]-1H-indole-2-carboxylic Acid Structure](https://www.chemicalbook.com/CAS/20211123/GIF/2212021-83-3.gif)




![(3aR,7aR)-4'-(benzo[d]izotiazol-3-il)](/uploads/32977/small/3ar-7ar-4-benzo-d-isothiazol-3-ylfc4b6.jpg?size=402x0)
